ProfileGDS4718 / 206078_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 41% 28% 41% 37% 39% 39% 39% 28% 46% 55% 42% 47% 38% 42% 33% 37% 39% 40% 48% 42% 42% 41% 31% 42% 45% 37% 44% 57% 40% 33% 36% 51% 51% 38% 34% 44% 37% 39% 27% 40% 45% 35% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4602649
GSM549102patient 115, normal, homogenized [OPG study]5.0813241
GSM549104patient 119, normal, homogenized [OPG study]4.4547828
GSM549108patient 138, normal, homogenized [OPG study]5.1102441
GSM549119patient 077, normal, homogenized [OPG study]4.8551337
GSM549133patient 032, cancer, homogenized [OPG study]4.911339
GSM549139patient 042, cancer, homogenized [OPG study]4.919239
GSM549099patient 107, normal, homogenized [OPG study]4.965739
GSM549109patient 139, normal, homogenized [OPG study]4.4637828
GSM549110patient 046, normal, homogenized [OPG study]5.280646
GSM549114patient 063, normal, homogenized [OPG study]5.7416755
GSM549122patient 082, normal, homogenized [OPG study]5.1036842
GSM549134patient 033, cancer, homogenized [OPG study]5.3047747
GSM549136patient 036, cancer, homogenized [OPG study]4.8234438
GSM549140patient 044, cancer, homogenized [OPG study]5.0497542
GSM549111patient 047, normal, homogenized [OPG study]4.6396733
GSM549113patient 057, normal, homogenized [OPG study]4.7821237
GSM549132patient 031, cancer, homogenized [OPG study]4.9461339
GSM549137patient 038, cancer, homogenized [OPG study]4.9642440
GSM549142patient 047, cancer, homogenized [OPG study]5.5519348
GSM549100patient 110, normal, homogenized [OPG study]5.1040442
GSM549107patient 135, normal, homogenized [OPG study]5.0813242
GSM549115patient 068, normal, homogenized [OPG study]5.0034141
GSM549116patient 072, normal, homogenized [OPG study]4.5717931
GSM549120patient 078, normal, homogenized [OPG study]5.0931942
GSM549131patient 030, cancer, homogenized [OPG study]5.1914945
GSM549118patient 074, normal, homogenized [OPG study]4.8371637
GSM549129patient 027, cancer, homogenized [OPG study]5.2266944
GSM549123patient 088, normal, homogenized [OPG study]5.937157
GSM549124patient 006, cancer, homogenized [OPG study]5.0305540
GSM549126patient 015, cancer, homogenized [OPG study]4.6818433
GSM549128patient 025, cancer, homogenized [OPG study]4.7831836
GSM549103patient 117, normal, homogenized [OPG study]5.6018651
GSM549117patient 073, normal, homogenized [OPG study]5.5441551
GSM549138patient 041, cancer, homogenized [OPG study]4.8712938
GSM549141patient 045, cancer, homogenized [OPG study]4.6460134
GSM549130patient 028, cancer, homogenized [OPG study]5.1918644
GSM549101patient 111, normal, homogenized [OPG study]4.8895237
GSM549105patient 128, normal, homogenized [OPG study]4.9817739
GSM549106patient 134, normal, homogenized [OPG study]4.3708627
GSM549112patient 048, normal, homogenized [OPG study]4.9803840
GSM549125patient 011, cancer, homogenized [OPG study]5.2543545
GSM549127patient 024, cancer, homogenized [OPG study]4.7408735
GSM549135patient 035, cancer, homogenized [OPG study]4.7844137